Evolus (EOLS) Accounts Payables (2017 - 2026)
Evolus (EOLS) posted Accounts Payables of $19.5 million for Q1 2026, down 16.4% on a QoQ basis from $23.4 million in Q4 2025, and up 20.73% year-over-year from $16.2 million in Q1 2025.
Evolus (EOLS) Accounts Payables (2017 - 2026) Analysis & Trends
Evolus' Accounts Payables history runs 10 years deep, the most recent figure standing at $19.5 million for Q1 2026.
- Quarterly Accounts Payables rose 20.73% year-over-year to $19.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.5 million (up 20.73% YoY) and the FY2025 annual result came in at $23.4 million, up 152.92% from the prior year.
- Accounts Payables was $19.5 million for Q1 2026 at Evolus, down from $23.4 million in the prior quarter.
- Across five years, Accounts Payables topped out at $23.4 million in Q4 2025 and bottomed at $4.3 million in Q4 2023.
- A 5-year average of $12.9 million and a median of $10.5 million in 2022 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2023 — Accounts Payables plunged 52.2% — and 2025, when it surged 152.92%.
- Evolus' Accounts Payables stood at $8.9 million in 2022, then plunged by 52.2% to $4.3 million in 2023, then surged by 116.25% to $9.2 million in 2024, then jumped by 152.92% to $23.4 million in 2025, then retreated by 16.4% to $19.5 million in 2026.
- Business Quant data shows EOLS's Accounts Payables at $19.5 million in Q1 2026, $23.4 million in Q4 2025, and $23.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | 19.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.53 Mn |
| Dec 31, 2025 | 23.36 Mn |
| Sep 30, 2025 | 22.96 Mn |
| Jun 30, 2025 | 23.31 Mn |
| Mar 31, 2025 | 16.18 Mn |
| Dec 31, 2024 | 9.24 Mn |
| Sep 30, 2024 | 13.84 Mn |
| Jun 30, 2024 | 10.28 Mn |
| Mar 31, 2024 | 11.22 Mn |
| Dec 31, 2023 | 4.27 Mn |
| Sep 30, 2023 | 11.76 Mn |
| Jun 30, 2023 | 7.84 Mn |
| Mar 31, 2023 | 10.19 Mn |
| Dec 31, 2022 | 8.94 Mn |
| Sep 30, 2022 | 8.56 Mn |
| Jun 30, 2022 | 10.49 Mn |
| Mar 31, 2022 | 7.57 Mn |
| Dec 31, 2021 | 6.09 Mn |
| Sep 30, 2021 | 7.37 Mn |
| Jun 30, 2021 | 8.06 Mn |